Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort [0.03%]
基于14年多中心队列研究的儿童NHR-APL患者全反式维甲酸和砷剂治疗过程中分化综合征的早期识别及认识
Zhong Fan,Liang-Chun Yang,Yi-Qiao Chen et al.
Zhong Fan et al.
Background: The combination of all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) has dramatically improved the cure rate of acute promyelocytic leukemia (APL). However, differentiation syndrome (DS) remains a sig...
Multicenter Study
Pharmacoepidemiology and drug safety. 2026 Jun;35(6):e70390. DOI:10.1002/pds.70390 2026
The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower-Middle-Income Countries [0.03%]
来自中低收入国家VigiBase报告中抗生素不合理使用和耐药性问题的信号检测分析及 pharmacoepidemiology 的研究:以药物警戒数据库作为数据来源
Hager Saleh,Joseph Mitchell,Cecilia Stålsby Lundborg et al.
Hager Saleh et al.
Background: Digital databases such as pharmacovigilance (PV) databases could provide unique opportunities to monitor trends in suspected antibiotic resistance, ineffectiveness, and misuse, extending beyond their tradition...
Optimizing Use of Real-World Data in Regulatory Decision Making for Medical Devices Used in Surgical Procedures [0.03%]
基于真实世界证据的手术器械监管决策优化研究进展
Guy Cafri,Florence Bourgeois,Paul Coplan
Guy Cafri
Purpose: In the United States, the Food and Drug Administration has provided guidance on the contexts in which real-world evidence (RWE) can be used to support regulatory decisions for medical devices. ...
Comparative Effectiveness and Safety of Three Oral Antihypertensive Therapies on Maternal and Infant Outcomes in a California Medicaid Population, 2016-2020 [0.03%]
基于加利福尼亚州医疗补助计划人口中三种口服降压药的疗效和安全性比较:2016-2020年母胎结局分析
Catherine Psaras,Erin Delker,Rebecca J Baer et al.
Catherine Psaras et al.
Purpose: To extend the Chronic Hypertension and Pregnancy (CHAP) trial findings, this study compared labetalol, nifedipine, and methyldopa initiation at or before 23 weeks' gestation in pregnant patients with chronic hype...
The Association Between MOG-IgG Positivity and mRNA SARS-CoV-2 Vaccination in Denmark: A Self-Controlled Case Series Study [0.03%]
丹麦MOG-IgG阳性与mRNA新型冠状病毒疫苗接种关联的自我控制病例系列研究
Tine Iskov Kopp,Anne Katrine Andreasen,Viktoria Papp et al.
Tine Iskov Kopp et al.
Purpose: Spontaneous reporting of a possible link between myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) and mRNA SARS-CoV-2 vaccination warrants further examination. Hence, the objective of...
Jamie L Smith,Molly M Jeffery,Jason S Egginton et al.
Jamie L Smith et al.
Purpose: To explore the opioid decision-making process of prescribers in primary care, surgery, and subspecialty pain management. Methods: ...
Prevalent-New User Design for Biosimilar Safety Using Saudi Real-World Data [0.03%]
基于沙特真实世界数据的生物类似药安全性新用户设计方法研究
Ohoud Almadani,Almaha Alfakhri,Ibrahim Asiri et al.
Ohoud Almadani et al.
Objective: Incidents of infections associated with biosimilar biological disease-modifying antirheumatic drugs (bDMARDs) have been communicated to the Saudi Food and Drug Authority (SFDA). This study aimed to evaluate the...
Letter to the Editor Regarding "Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study" [0.03%]
关于「短期使用复方新诺明治疗无并发症膀胱炎的安全性:一项全国性回顾队列研究」的来信
Toshiki Fukasawa,Hisashi Urushihara,Takayuki Okura et al.
Toshiki Fukasawa et al.
Direct Oral Anticoagulant Consumption and the Risk of Acute Interstitial Lung Diseases: A Case-Crossover Study Using Japanese Administrative Data [0.03%]
口服抗凝药的使用与急性间质性肺疾病风险的关系:基于日本行政数据的病例交叉研究
Keisuke Anan,Takahiro Itaya,Yuki Kataoka et al.
Keisuke Anan et al.
Background: Direct oral anticoagulants (DOACs) offer advantages over warfarin; however, concerns exist regarding their association with acute interstitial lung diseases (ILDs). This study investigated the risk of acute-on...
The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study [0.03%]
加拿大不列颠哥伦比亚省炎症性肠病患者生物类似药转换政策的长期影响:一项回顾性的基于人群的研究
Mark Harrison,Sandra Blitz,Michael Law et al.
Mark Harrison et al.
Background and aims: In 2019, British Columbia (BC) became the first jurisdiction in North America to introduce a mandatory non-medical switching (NMS) policy requiring patients with Crohn's disease (CD) and ulcerative co...